 |
인쇄하기
취소
|
Hanmi likely to post double-digit growth
Market observers projected on March 26 that Hanmi Pharm's progress this year will fall into the double-digit territory.
“The market consensus is that boosted by robust sales of new products, including esomeprazole and Amozaltan (amodipine plus Cozaar), this year’s Hanmi's turnover is around 620 billion won, up 11.2 percent from the previous year,'' said an analyst at KB Securities.
“Its o...
“The market consensus is that boosted by robust sales of new products, including esomeprazole and Amozaltan (amodipine plus Cozaar), this year’s Hanmi's turnover is around 620 billion won, up 11.2 percent from the previous year,'' said an analyst at KB Securities.
“Its o...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.